Mohamed Ahmed Al-Kasim

Mohamed Ahmed Al-Kasim

Auto-generated profile, based on publicly available information

Mohamed Ahmed Al-Kasim

Department of Pharmacology, College of Pharmacy, Jazan University, Jazan, Saudi Arabia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Drug Delivery
Verified
Journal Article
Open access
HMHafiz Antar Makeen
Hafiz Antar Makeen
Syam MohanSyam Mohan
Syam Mohan
MAMohamed Ahmed Al-Kasim
Mohamed Ahmed Al-Kasim
IAIbraheem Mohammed Attafi
Ibraheem Mohammed Attafi
RARayan Ahmed
Rayan Ahmed
MAMohammad Alam
Mohammad Alam
NLC containing Gefitinib (NANOGEF) was prepared using stearic acid, sesame oil and surfactants (sodium lauryl sulfate and tween 80). NANOGEFs were evaluated for particle size, polydispersity index (PdI), zeta potential, entrapment efficiency (EE), stability, release studies and cytotoxicity studies (MTT assay). The optimized NANOGEF exhibited particle size of 74.06 ± 9.73 d.nm, PdI of 0.339 ± 0.029 and EE of 99.76 ± 0.015%. The TEM study revealed spherical shape of NANOGEF formulations. The slow and sustained release behavior was exhibited by all NANOGEFs. The effects of surfactants were observed not only on particle size but also on zeta potential, entrapment efficiency, stability and release studies. The MTT assay revealed 4.5 times increase in cytotoxicity for optimized NANOGEF (IC50 = 4.642 µM) when compared with Gefitinib alone (IC50 = 20.88 µM in HCT-116 cells). Thus NANOGEF may be considered as a potential drug delivery system for the cure of colon cancer.